Skip to main content
Gil Melmed, MD, Gastroenterology, Los Angeles, CA, Cedars-Sinai Medical Center

GilYMelmedMD

Gastroenterology Los Angeles, CA

Inflammatory Bowel Disease

Professor of Medicine, Cedars Sinai Medical Center and David Geffen School of Medicine at UCLA

Dr. Melmed is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Melmed's full profile

Already have an account?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 2003 - 2006
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Internal Medicine, 2000 - 2003
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2000

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2026
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Utility of Video Capsule Endoscopy for Longitudinal Monitoring of Crohn’s Disease Activity in the Small Bowel: A Prospective Study  
    Gil Y Melmed, Marla C Dubinsky, David T Rubin, Shabana F Pasha, Atsushi Sakuraba, Felix Tiongco, Ira Shafran, Jonathan A Leighton, Gastrointestinal Endoscopy

Press Mentions

  • Oshi Health Names Dr. Gil Melmed to Medical Advisory Board
    Oshi Health Names Dr. Gil Melmed to Medical Advisory BoardJuly 26th, 2022
  • Dr. Gil Melmed Joins Oshi Health Medical Advisory Board
    Dr. Gil Melmed Joins Oshi Health Medical Advisory BoardJuly 26th, 2022
  • Impaired Humoral, Upheld Cellular Responses in Patients with IBD After SARS-CoV-2 Vaccine
    Impaired Humoral, Upheld Cellular Responses in Patients with IBD After SARS-CoV-2 VaccineMay 27th, 2022
  • Join now to see all

Hospital Affiliations